@article {Krugner-Higby:2003:1532-0820:270,
title = "Liposome-Encapsulated Oxymorphone Hydrochloride Provides Prolonged Relief of Postsurgical Visceral Pain in Rats",
journal = "Comparative Medicine",
parent_itemid = "infobike://aalas/cm",
publishercode ="aalas",
year = "2003",
volume = "53",
number = "3",
publication date ="2003-06-15T00:00:00",
pages = "270-279",
itemtype = "ARTICLE",
issn = "1532-0820",
eissn = "2769-819X",
url = "https://www.ingentaconnect.com/content/aalas/cm/2003/00000053/00000003/art00007",
author = "Krugner-Higby, Lisa and Smith, Lesley and Clark, Melanee and Heath, Timothy D. and Dahly, Elizabeth and Schiffman, Beth and Hubbard-VanStelle, Scott and Ney, Denise and Wendland, Allyson",
abstract = "Adequate pain control is necessary for optimal postsurgical recovery and humane treatment of laboratory and companion animals. Opioid drugs are currently the most potent analgesic agents available in human and veterinary medicine. Long-acting formulations of opioid drugs confer several
important advantages over standard pharmaceutical preparations, especially for use in animals. A long-acting formulation of oxymorphone hydrochloride was produced by encapsulation into liposomes. Liposome-encapsulated (LE) oxymorphone was tested in a rat model of visceral postoperative pain.
Rats were given one subcutaneous injection of LE oxymorphone (1.2 or 1.6 mg/kg of body weight) or standard oxymorphone (0.3 mg/kg) at the time of intestinal transection or resection. A single administration of LE oxymorphone hydrochloride was as effective for relief of postoperative pain in
rats (P = 0.18), as were multiple (q4 h or q8 h) injections of 0.3 mg/kg of the standard pharmaceutical preparation. The rats given LE oxymorphone prior to intestinal resection also had significantly higher body weight at three and seven days after surgery than did rats that were given
standard oxymorphone. In conclusion, LE oxymorphone was effective in treating visceral pain associated with intestinal surgery in rats. On the basis of body weight gain, rats treated with LE oxymorphone had improved recovery outcome, compared with rats treated with repeated injections of standard
oxymorphone.",
}